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Abstract 
 
Background: To compare the Induction – Delivery 
interval between Oral and Vaginal route of Misoprostol at 
term. 
Methods: In this comparative study , one  hundred 
women at term with indications for induction of labour  
and Bishop score < 5, having no other obstetric and 
maternal contraindications for induction of  labour were 
randomly assigned to receive  Misoprostol 50 g orally and 
50 g vaginally every 6 hours for 24 hours for a total  of 
four doses. Repeated doses were given until Bishop score 
> 8 was achieved or spontaneous rupture of membranes 
occurred. Student’s t test was applied to compare 
induction delivery interval between oral and vaginal 
groups and statistical significance was assigned to P- value 
< 0.05. 
Results: The median induction to delivery interval time 
was significantly shorter with vaginal Misoprostol (11.0 h), 
compared with oral Misoprostol (14.1 h, p= 0.036). There 
was no difference between two routes of administration 
with respect to rates of hyperstimulation or neonatal 
asphyxia.  
Conclusions: Compared with oral Misoprostol, 
vaginal Misoprostol for induction of labour at term results 
in a shorter induction to delivery interval time. There were 
more caesarean section in the vaginal Misoprostol group. 
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Introduction 
Induction of labour is to start uterine 
contraction prior to their spontaneous onset, 
accompanied with cervical dilatation, effacement and 
descent of fetal presenting part. About 20% of 
pregnant women will have labour induced for variety 
of reasons. Induction does not usually involve just a 
single intervention but it is a complex set of 
interventions and as such present challenges for both 
clinicians and mother. 1 
Pharmacologic agents available for cervical 
ripening and labour induction include Prostaglandins 
(PGE2), Misoprostol (PGE1), Mifepristone and Relaxin. 
In the absence of a ripe or favourable cervix , a 
successful vaginal birth is less likely. Therefore, 
cervical ripening for induction should be assessed 
before a regimen is selected. Assessment is 
accomplished by calculating a Bishop score. 2 
      Induction of labour at term in the presence of an 
unfavourable cervix is associated with an increased 
risk of failed induction and caesarean section. The use 
of prostaglandins preparations with or without 
oxytocin infusion, is widely recognized and accepted 
as standard method of labour induction. Prostaglandin 
preparations have been shown to reduce induction 
time and the risk of failed induction. However, natural 
prostaglandins are inconvenient to use, expensive and 
difficult to store , as they require refrigeration.  3-5 
      There has been a growing interest in using 
Misoprostol, a prostaglandin E1 analogue, as an 
alternative agent for induction of labour.It is less 
expensive than dinoprostone and requires no special 
storage arrangement.6  Misoprostol is an oral 
prostaglandin compound, structurally related to 
prostaglandin E1 and manufactured as a treatment for 
peptic ulcer disease. Though unlicensed for this 
indication, it is being used increasingly in induction of 
labour with vaginal and oral administration.  7,8 
 
Patients and Methods 
     In this comparative  study oral and vaginal routes 
of Misoprostol, for induction of labour, at term was 
carried out in the Department of Obstetrics and 
Gynaecology, Railway Hospital Rawalpindi from 
February 2008 – August 2008. All women requiring 
induction of labour at or beyond term (> 37 weeks 
gestation) and Bishop score <5 were included in the 
study. Patients with previous Caesarean section or any 
other uterine scars, multiple pregnancies, Bishop score 
> 5, placenta previa, mal-presentations, ruptured 
membranes were excluded from the trial. After full 
informed consent, women were randomly assigned to 
receive oral or vaginal Misoprostol tablet. After 
complete history and examination, a reassuring fetal 
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heart tracing was confirmed with a cardiotocograph. 
      Vaginal examination was performed to assess the 
Bishop’s score. Patients were then given 50 
micrograms Misoprostol orally. Those in vaginal 
group received 50 micrograms tablet into posterior 
fornix of vagina. The dose of 50 micrograms was 
repeated in both groups if there was no uterine 
activity or if the uterine contractions were mild (less 
than 2 contractions in 10 minutes). A maximum of 4 
doses were given. 
      Fetal well being was confirmed by 
cardiotocography and Bishop’s score assessed prior to 
every dose of Misoprostol tablet either given vaginally 
or orally. If a diagnosis of labour was made or the 
Bishop’s score was 8 or more the woman was 
transferred to the labour ward for artificial rupture of 
membranes. The use of oxytocin was according to the 
labour ward protocol and was not started less than 4 
hours after the last dose of Misoprostol. It was 
administered through an infusion with an initial dose 
of 1 mU / min to a maximum of 32 mU/min.  
      A partogram recording progress of labour was 
maintained. If cervix was not favourable for artificial 
rupture of membrane after 4 doses of Misoprostol 
tablets, the induction was considered to have failed 
and the woman was offered caesarean section. 
Neonatal outcome was assessed by 1 min and 5min 
APGAR score, need for intubation, positive pressure 
ventilation and NICU admission. 
The data was entered on SPSS Version 10 for 
statistical analysis. Student’s t test was applied to 
compare induction delivery interval between oral and 
vaginal groups. Statistical significance was assigned to 
P- value < 0.05.  
 
Results   
There were no differences in the indications 
for labour induction with postdate being the major 
indication in both groups. Induction to delivery 
interval time was three hours shorter in women who 
received Misoprostol vaginally, (11hours in vaginal 
group and 14.1 hours in oral group) (Table 1). Vaginal 
Misoprostol required significantly more oxytocin 
augmentation (54% vs. 26%).  
There was no significant difference between 
the two groups with respect to secondary outcome 
measures,including  effects of the medication on 
uterine activity (e.g. tachysystole, hypertonus, 
hyperstimulation), and mode of delivery(Table 2). 
Tachysystole was identified in three women (6%) in 
the oral group and eight women (16%) in the vaginal 
group .No one in either group was identified as 
having hypertonus. One women (2%) in oral group 
required emergency caesarean section.  
 
Table 1:  Primary Induction Outcome  
 Oral(n = 50) Vaginal(n =50) 
Number of doses 2.21 1.39 
Induction to delivery 
interval 
14.1 11.0 
Oxytocin augmentation 27(54%) 13(26%) 
 
Table 2: Secondary Induction Outcome   
 Oral Vaginal 
 
Mode of Delivery 
Caesarean Section 
SVD 
 
1      (2%) 
49   (98%) 
 
3    (6%) 
47 (94%) 
Tachysystole 3     (6%) 8   (16%) 
Hypertonus 0 0 
Hyperstimulation 0 0 
Uterine Rupture 0 0 
Nausea, Vomiting, Fever 0 0 
Failed Induction 0 0 
 
Table 3:  Neonatal Outcomes 
 Oral( n= 50 ) Vaginal( n= 50 ) 
1 min Apgar <7 3     (6%) 2       (4%) 
5 min Apgar <7 0 2       (2%) 
Need for PPV 1      (2%) 3       (6%) 
Need for Intubation 0 1       (2%) 
NICU Admission 0 1       (2%) 
 
      Three women (6%) in vaginal group required 
emergency caesarean section for non – reassuring fetal 
heart rate tracings, but these were not in association 
with tachysystole or hypertonus. None of the women 
reported adverse effects such as diarrhea, nausea or 
vomiting during the induction process. 
      There were 2 infants (4%) in vaginal group 
compared with 3 infants (6%) in the oral group with 1 
minute Apgar score less than 7. There were 2 infants 
(4%) in vaginal group with five minute Apgar score <7 
(4% Vs 0).1 infant (2%) in oral group required positive 
pressure ventilation, compared with the vaginal group 
which were 3 (6%). However, there was only 1 infant 
(2%) in the vaginal group who required intubation 
because of meconium aspiration (Table 3). 
 
Discussion  
      There is increasing evidence that Misoprostol, 
administered either vaginally or orally, is as effective 
as conventional method for induction of labor at term.8 
Women who received Misoprostol vaginally required 
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less dosage and experienced faster induction to 
delivery interval times with less need for oxytocin 
augmentation when compared with similar group of 
women receiving oral Misoprostol. 9 
      Kwon et al (2001)found that giving 50 micrograms 
Misoprostol vaginally every 6 hours resulted in a 
significantly shorter induction to delivery interval time 
compared to 50 micrograms Misoprostol orally 6 
hours with no significant difference in tachysystole 
and hyperstimulation.9 
      In present study, more women in oral group (54%) 
required oxytocin augmentation than in vaginal group 
(26%).This finding is in agreement with Kwon et al 
(2001) who found that women in the oral group 
required significantly more oxytocin augmentation 
than vaginal group (78.2% Vs 50%), but is in contrast 
to Wing et al.(49.6% Vs 52.2%). 9,10 
      There were more emergency caesarean section in 
the vaginal group (6%). The indications for emergency 
caesarean section in the vaginal Misoprostol group 
included non-reassuring fetal heart tracings such as 
the presence of late decelerations or prolonged 
bradycardia. It is interesting to note that hypertonus or 
tachysystole was not noted in any of the three cases. A 
higher rate of non reassuring fetal heart tracings and 
hyperstimulation associated with vaginal Misoprostol 
compared with oral Misoprostol has been reported. 
Large studies are required to adequately address the 
risk of caesarean section. 
      There was no statistical difference between oral 
and vaginal Misoprostol with one minute Apgar score 
<7 (6% Vs 4%).There were two infants in vaginal 
group (4%) with 5 minute Apgar score <7. The first 
infant had five minute Apgar score of 5 & 8 
respectively. This infant required positive pressure 
ventilation at delivery and was admitted in NICU for 
two days postpartum but had no clinical sequelae of 
asphyxia. This infant required no further 
investigations other than for hyperbilirubinemia and 
needed no further admission in hospital. The second 
infant had one and five minute Apgar score of 5 and 
10 respectively. This infant also required positive 
pressure ventilation at delivery and was admitted 
under observation for one day postpartum but had no 
clinical sequalae of asphyxia. This infant required no 
investigation and no further admission in hospital. 
 
Conclusion  
The optimum required dose of Misoprostol still needs 
to be determined .  
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